Exscientia, MD Anderson Collaborate on AI-Driven Oncology Drug Discovery and Development

Retrieved on: 2022-11-14 20:26:35

Tags for this article:

Health

Pharmaceutical sciences

Drug discovery

Clinical pharmacology

Pharmaceutical industry

Design of experiments

Medicinal chemistry

University of Texas MD Anderson Cancer Center

Click the tags to see associated articles and topics

Exscientia, MD Anderson Collaborate on AI-Driven Oncology Drug Discovery and Development. View article details on HISWAI: https://www.insideprecisionmedicine.com/topics/oncology/oncologics/exscientia-md-anderson-collaborate-on-ai-driven-oncology-drug-discovery-and-development/

Excerpt

Artificial intelligence has opened up new possibilities in cancer research, enabling us to use deep learning multi-omics within our precision medicine ...

Article found on: www.insideprecisionmedicine.com

View Original Article